{"ticker": {"uuid": "72289590-bc17-425e-b7b2-897f6346ef5c", "symbol": "GLAXO", "name": "GlaxoSmithKline Pharmaceuticals Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Glaxosmithkline Pharmaceuticals - Concurrent Losers: 13 stocks decline for 5 consecutive sessions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQb1NGQmVHQ1p6MS1sNXViNnJ5TVpCcjd2T1BQS1VTM0pRVWNaWWt0c1pfWGphdk9aUlRkY25hQlN5bE91c05sLXlVSWVkQTdjZmVtcDFONm16azhmN1Z6ck5GTXJDMl9pWnR1XzYtY1ZIa0FoVi1wZE5rWmpEX0I1MjRfTWpLUUlXZDRtZjlSUkV6Nzhkb0gxNDJhcUdTUlNBamctNmNSQWpwV2tOU1FNMG54SDZCTXlRZUwtcGxHalBZVXJQQlVRbzYtcmJsQnBMa3Vvd3o2YjlrNkF6T1N0anYzc3RpczRBYUZEUWZwUm1rNVBvaUtDREJ3?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) After Its Full-Year Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxQbEY4SFVJTnBPZ0VDVDI5cFU0Y3YyYWhGc0dUT0JBNGFwa2MwRFZJWUZwckFJeWVPaUY2d2tpWGFoVnZZYmRHaFYxNU8zWDB0VnNwYnFOS1VkTDYxOWo2RUxudEN0SlRPQ1J0dl95Q1cxQk5WandMclZFTENMSlRMakx2SmcwekdWYVo4cnVzOXdFYmprcC1WRHBBUkVGZmpiSjQwVGhJQ05ydmNFR2JHbHoxYjVMNGJfVFhoRDF4OUQ2U2dtVE44Y2FxTy1RaHhyWXFrTjk3M1VLYlkwRkozcVVscmhEZjlESFpTS25DUE1qb0xaa2NwMVVIbk9Pb2vSAYQCQVVfeXFMTWRLaU1LYjhiWF85S2RYNlQ3ZVVUSDJnTXFLSEs2TnQtRGE4ck80ekRobFhoNTRIbm8yaER5d0lERVUydy1ucW1NS3dBcVJhTVJTWFZia2dsSGthVnk4TkUwdnNmSjdkcXlMbGM2V1A3a0lDc2dIQTVzbHJmN2FsSXM3c0dQTFd1Nk85M2NWeEYwTWR4cjhJb2lIa1RpcHM5dF96ZWlacHA2TTRHV2V1NVl5NjZlazd4Tk9ZN0RvaXFxOG5ubEhRaFF5ZGZ6NlZibHRlQWY5WXF0RFFqQVFBYjFnU184R1FoNUtnaUJucFVDZnNtN3JZa3JLN1pWbU9Kd21YNlg?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharma stock (INE159A01016): Q4 profit rises 6% YoY", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQaGI0c3QteWpST1ZzR0RIVW42VFBwTkVGQW5oWHlNa1BfNjZvX2hOM3JVUXB6SG5XV0VZV0VlMi1lYVdqemxsRDJHdlc3bnVpMmJOUFZ3S0QzNGJ3Z2JpcHlobnpaYnc5dmdaWF9wMUF6a0ttSHJET2cwMTZJa3U5M3h3YkNJcTkzenpfcmI2eTFzZU5ObXctV211ek56cDJDWlE2cG5idVJpVE10QlBoNk9iYXE0TTdkN0hzRzFrck1DUkta?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Schedules Board Meeting on May 13, 2026 for FY26 Results Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQnhlcndjc25FSkw2c0JuNU5aRmVWV3I2ZklkS05CalhBWHFkallrekthaURJbFlqNzA2Vkw4R0gzQlhTcjBGR1RoQ2JXVVlJUm5ZRjBjWDRVbzhkUG84UDdnTFpwRmx1STlnTTFEamVqalJwX0EwSm40SU1Vd1VBLTNZeE1scm5JdnJTd2NsSm9QQmNfQ1lpNjRFSHZQYUJGem9DOUtvODE3Smc2Qkw4YkpwOVJsb2w5SFU4c0tfTU5MWngzZng5T2pRcURXUjlTRGE4YnE0QmNCM1RwU2wtRThyOTlIVk9w?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Appoints Vinay Subramanian as Commercial Head - Oncology", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQam8zQmVtVkwyU1JKa0RCNmN4VVJ4YVRyVEFDMkR4ZGJBemJ3N3ZYU0JjMW14N1JzS1ppaW55YXJkbFlwZGZ2S3Q4MXBmaDVma0U0MGxSZDltekNVdHpjOVdWYmp5c3FiaFJPOGM5SU5SMWZYTnZKUkVBcmNSZTNtRXJKVXVnX0dob0pZRkdhalVtRFZmQ043VWtMRmpmXzlycC1fWmFIXzBabG1vemktckRXcmh6LWNYX0dvOTNPQ282TDU5UGp0dHVMQWNYcTNCTGJWY29XR1FXMkk?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Receives Rs 2.01 Crore TDS Demand Order from Tax Authority", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPZkwzRUhSRlNSWVpDdWJXdjg4S2daZFhBenFUNzhWYlkwRlNRdW1ER3FFcXNwSWw3cWVveUVscEE3R2hadGJRRkJVMngwc091TVAtMUpOOVpWUW1QeTBNU1RyLWxESEJrM2VTc3BHZjcxbmZnOTRUdGFRTGh1YWl0el9tY19LdkdfU1F5aWFkUmVYODJmU2gxVnc3ckc4a3d1VmtobHd5WUpxUTE2N01tR1ZGbFEycVpnb3FpVkZfeTEya1dJcUFsNC1WV3hvVUF3RUFEXzNGV3UyaEwwUTFucQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Juby Chandy Steps Down As Whole-Time Director And CFO Of GlaxoSmithKline Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZ0VUUUV2MXVNRzhxSVhYMW5vMzRGN2JLZkFlSVVxUDJkV21oc3NscUdSSjVPQlNla0hNeFZQMWJUNGxLYTkzM2VtQkRlTlg4bTlmeGhzeGc0bUpHa1AxeXVkNVdpbGlzQlRjbTFrZk9XLU1rMXRTQ2JiZjdBdzhjYlI2b252MWMzaVdXcUlTWW5kZVo3WGg4WGZRU2hWSWhkNzJYbGJXbDFYXzVBS1EwT3hLbXNRQzd2NWNqNnR6bWZHcGVZc24ySHFldl8tZnJV?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Issues Postal Ballot Notice for CFO Appointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSndVcHhlWmRiUHBsb2xJQ2wwMThoaW1JTHotLTNmbU1QV0FqeFY0R19sV1RiUEFQaXZJUUFYZTNpa19nb2ljZEJIMFgzZEJZTDBnMkNtNDU4c3JGWHRPbTJhMXhYR1BXOGdiXzRIVklHaEhybGVZZDVrbWZ6MUYyTUdEVV9LZ25VeHlCb2hNazBHQXlCeGlEcVhNR0pRclV3M2huSzdHOGROaGFON0l4Tm0xSzZxejVzdVZzbWxwN1Q5bXZrS2lJSlQ0OGFNZ2VvaTZ3WF9kY2s3Q3ZE?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-07T08:00:00+00:00", "published_display": "07 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) market cap surged \u20b932b last week, public companies who have a lot riding on the company were rewarded", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Not Telling The Story For GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNaTVxR2dGcTB5MTVVYmZaREdRWElzN0I5TUdjZ0JxWHlkbEdqWFFnZXJXZnhyWmpjN1d1bVp1bDRGYWhEVUxROHNPMXRQWms3b0lXT1d2c3NDbmxBU1FFMFU4djdJc041djhLaF9ZZkJaMUg1b1ZyNGZ5clNwaFB2R0lteUhxX1BJaVVGWFphOTNFUUFRTmc?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T14:39:58+00:00", "published_display": "03 Jan 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Weakness in GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Stock Prove Temporary Given Strong Fundamentals?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOem5ud3gyWk1JUTFENXNoLUtHU3dtZ1JYalZXVzFPR1BmbUpuQ0k4OW52VG5MSGtGMk9uMlQ4Wk9NU05uZmNsU2pxaFQxNGNXMzBtSjAtQVBlN2FPYkdHNmxsOW1adjVjYjFSMkR5QWE4T3NURk9EZVlBckVURU1uM1ZzSkRtOF9NdndTNFpRNDNtblBUZ2paRTJZMUpJZDdMWGF5anhGMThCN1FXSjVUNUtyQTFjZDg5ek5vcWkzdVhNZVhjeWRNVTBiejR5MVhGWHY1UFdPSkZ0WENxTVhZMmVvUQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's GlaxoSmithKline Pharma posts first revenue drop in over two years", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZE1CTk5mTFE1a3c5WjFkMENpOVhidmdnVk5falBPd0ZKbWsxcGhPTkE2cUV6eGUtYUs2NmV6Q19ldTdYSno4REM3UkVGdGJGNFhXUUR2OU5NR19CY0JycE1BWERQdnhseFRiaElJSlhJY1JYdmN2a1NOVWxLRmtaODRmZXVMb0RVZFN4VUJNQ3VaUWMwSms0UVVtRmJFQWlKRUJybU9JQTh1a3pmcHJ0UUxON19UWDZp?oc=5", "source_name": "Reuters", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's GlaxoSmithKline Pharma reports profit rise on strong demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNLWgzY0tHcDg0NnI4S2RpSnliM2wwSFBNZlo0Q2lyTk5zNVRpY0htSFU2azlTenV4SWpkUEtONmZ2WkpjRUk5aFZ5WE9SRHRHQVdXRFFTVzJ2ejZudEgyMVZPOHZaY0ZWckVKanc0OWV6bENnSnB0eWowN0FvbFZmd1F4dUZEcS1OUzFkU2Nab1k4dWlpWFZZVDNuUzR4OXRpOW1TOXp3dFVnX0FNa0p0bmdLQjByYWN5VTJXN3pRNmxscmdkSVBPMExFTjY1RlVC?oc=5", "source_name": "Reuters", "published_at": "2025-05-13T07:00:00+00:00", "published_display": "13 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Glaxosmithkline Pharmaceuticals - Concurrent Losers: 13 stocks decline for 5 consecutive sessions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQb1NGQmVHQ1p6MS1sNXViNnJ5TVpCcjd2T1BQS1VTM0pRVWNaWWt0c1pfWGphdk9aUlRkY25hQlN5bE91c05sLXlVSWVkQTdjZmVtcDFONm16azhmN1Z6ck5GTXJDMl9pWnR1XzYtY1ZIa0FoVi1wZE5rWmpEX0I1MjRfTWpLUUlXZDRtZjlSUkV6Nzhkb0gxNDJhcUdTUlNBamctNmNSQWpwV2tOU1FNMG54SDZCTXlRZUwtcGxHalBZVXJQQlVRbzYtcmJsQnBMa3Vvd3o2YjlrNkF6T1N0anYzc3RpczRBYUZEUWZwUm1rNVBvaUtDREJ3?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) After Its Full-Year Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharma stock (INE159A01016): Q4 profit rises 6% YoY", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQaGI0c3QteWpST1ZzR0RIVW42VFBwTkVGQW5oWHlNa1BfNjZvX2hOM3JVUXB6SG5XV0VZV0VlMi1lYVdqemxsRDJHdlc3bnVpMmJOUFZ3S0QzNGJ3Z2JpcHlobnpaYnc5dmdaWF9wMUF6a0ttSHJET2cwMTZJa3U5M3h3YkNJcTkzenpfcmI2eTFzZU5ObXctV211ek56cDJDWlE2cG5idVJpVE10QlBoNk9iYXE0TTdkN0hzRzFrck1DUkta?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Schedules Board Meeting on May 13, 2026 for FY26 Results Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQnhlcndjc25FSkw2c0JuNU5aRmVWV3I2ZklkS05CalhBWHFkallrekthaURJbFlqNzA2Vkw4R0gzQlhTcjBGR1RoQ2JXVVlJUm5ZRjBjWDRVbzhkUG84UDdnTFpwRmx1STlnTTFEamVqalJwX0EwSm40SU1Vd1VBLTNZeE1scm5JdnJTd2NsSm9QQmNfQ1lpNjRFSHZQYUJGem9DOUtvODE3Smc2Qkw4YkpwOVJsb2w5SFU4c0tfTU5MWngzZng5T2pRcURXUjlTRGE4YnE0QmNCM1RwU2wtRThyOTlIVk9w?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Appoints Vinay Subramanian as Commercial Head - Oncology", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQam8zQmVtVkwyU1JKa0RCNmN4VVJ4YVRyVEFDMkR4ZGJBemJ3N3ZYU0JjMW14N1JzS1ppaW55YXJkbFlwZGZ2S3Q4MXBmaDVma0U0MGxSZDltekNVdHpjOVdWYmp5c3FiaFJPOGM5SU5SMWZYTnZKUkVBcmNSZTNtRXJKVXVnX0dob0pZRkdhalVtRFZmQ043VWtMRmpmXzlycC1fWmFIXzBabG1vemktckRXcmh6LWNYX0dvOTNPQ282TDU5UGp0dHVMQWNYcTNCTGJWY29XR1FXMkk?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Receives Rs 2.01 Crore TDS Demand Order from Tax Authority", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPZkwzRUhSRlNSWVpDdWJXdjg4S2daZFhBenFUNzhWYlkwRlNRdW1ER3FFcXNwSWw3cWVveUVscEE3R2hadGJRRkJVMngwc091TVAtMUpOOVpWUW1QeTBNU1RyLWxESEJrM2VTc3BHZjcxbmZnOTRUdGFRTGh1YWl0el9tY19LdkdfU1F5aWFkUmVYODJmU2gxVnc3ckc4a3d1VmtobHd5WUpxUTE2N01tR1ZGbFEycVpnb3FpVkZfeTEya1dJcUFsNC1WV3hvVUF3RUFEXzNGV3UyaEwwUTFucQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Juby Chandy Steps Down As Whole-Time Director And CFO Of GlaxoSmithKline Pharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZ0VUUUV2MXVNRzhxSVhYMW5vMzRGN2JLZkFlSVVxUDJkV21oc3NscUdSSjVPQlNla0hNeFZQMWJUNGxLYTkzM2VtQkRlTlg4bTlmeGhzeGc0bUpHa1AxeXVkNVdpbGlzQlRjbTFrZk9XLU1rMXRTQ2JiZjdBdzhjYlI2b252MWMzaVdXcUlTWW5kZVo3WGg4WGZRU2hWSWhkNzJYbGJXbDFYXzVBS1EwT3hLbXNRQzd2NWNqNnR6bWZHcGVZc24ySHFldl8tZnJV?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Issues Postal Ballot Notice for CFO Appointment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSndVcHhlWmRiUHBsb2xJQ2wwMThoaW1JTHotLTNmbU1QV0FqeFY0R19sV1RiUEFQaXZJUUFYZTNpa19nb2ljZEJIMFgzZEJZTDBnMkNtNDU4c3JGWHRPbTJhMXhYR1BXOGdiXzRIVklHaEhybGVZZDVrbWZ6MUYyTUdEVV9LZ25VeHlCb2hNazBHQXlCeGlEcVhNR0pRclV3M2huSzdHOGROaGFON0l4Tm0xSzZxejVzdVZzbWxwN1Q5bXZrS2lJSlQ0OGFNZ2VvaTZ3WF9kY2s3Q3ZE?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-07T08:00:00+00:00", "published_display": "07 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) market cap surged \u20b932b last week, public companies who have a lot riding on the company were rewarded", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Not Telling The Story For GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline Pharmaceuticals Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNaTVxR2dGcTB5MTVVYmZaREdRWElzN0I5TUdjZ0JxWHlkbEdqWFFnZXJXZnhyWmpjN1d1bVp1bDRGYWhEVUxROHNPMXRQWms3b0lXT1d2c3NDbmxBU1FFMFU4djdJc041djhLaF9ZZkJaMUg1b1ZyNGZ5clNwaFB2R0lteUhxX1BJaVVGWFphOTNFUUFRTmc?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T14:39:58+00:00", "published_display": "03 Jan 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Weakness in GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Stock Prove Temporary Given Strong Fundamentals?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GlaxoSmithKline India reports higher second-quarter profit on specialty medicine growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOem5ud3gyWk1JUTFENXNoLUtHU3dtZ1JYalZXVzFPR1BmbUpuQ0k4OW52VG5MSGtGMk9uMlQ4Wk9NU05uZmNsU2pxaFQxNGNXMzBtSjAtQVBlN2FPYkdHNmxsOW1adjVjYjFSMkR5QWE4T3NURk9EZVlBckVURU1uM1ZzSkRtOF9NdndTNFpRNDNtblBUZ2paRTJZMUpJZDdMWGF5anhGMThCN1FXSjVUNUtyQTFjZDg5ek5vcWkzdVhNZVhjeWRNVTBiejR5MVhGWHY1UFdPSkZ0WENxTVhZMmVvUQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's GlaxoSmithKline Pharma posts first revenue drop in over two years", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZE1CTk5mTFE1a3c5WjFkMENpOVhidmdnVk5falBPd0ZKbWsxcGhPTkE2cUV6eGUtYUs2NmV6Q19ldTdYSno4REM3UkVGdGJGNFhXUUR2OU5NR19CY0JycE1BWERQdnhseFRiaElJSlhJY1JYdmN2a1NOVWxLRmtaODRmZXVMb0RVZFN4VUJNQ3VaUWMwSms0UVVtRmJFQWlKRUJybU9JQTh1a3pmcHJ0UUxON19UWDZp?oc=5", "source_name": "Reuters", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "India's GlaxoSmithKline Pharma reports profit rise on strong demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNLWgzY0tHcDg0NnI4S2RpSnliM2wwSFBNZlo0Q2lyTk5zNVRpY0htSFU2azlTenV4SWpkUEtONmZ2WkpjRUk5aFZ5WE9SRHRHQVdXRFFTVzJ2ejZudEgyMVZPOHZaY0ZWckVKanc0OWV6bENnSnB0eWowN0FvbFZmd1F4dUZEcS1OUzFkU2Nab1k4dWlpWFZZVDNuUzR4OXRpOW1TOXp3dFVnX0FNa0p0bmdLQjByYWN5VTJXN3pRNmxscmdkSVBPMExFTjY1RlVC?oc=5", "source_name": "Reuters", "published_at": "2025-05-13T07:00:00+00:00", "published_display": "13 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 15, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 10, "score": 58, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 77, "events": [{"event": "earnings", "label": "Earnings", "weight": 4.9, "count": 7}, {"event": "general", "label": "Market update", "weight": 4.55, "count": 7}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 2438.2, "latest_week": "2026-07-10", "one_week_move": 1.8, "four_week_move": 14.9, "twelve_week_move": 1.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.880049, "market_dynamics_buy_signal": false, "relative_strength": -1.320779, "fair_value_gap": 3.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.2904, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.8% over one week, +14.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "Reuters", "count": 3}, {"label": "The Economic Times", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "CNBC TV18", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Earnings", "count": 7}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.8% over one week, +14.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Glaxosmithkline Pharmaceuticals - Concurrent Losers: 13 stocks decline for 5 consecutive sessions"}], "updated_at": "2026-07-17T07:52:17.775957+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}